Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;64(2):246-253.
doi: 10.1007/s12020-018-1812-0. Epub 2018 Nov 12.

Quality of life assessment in patients with HNF1A-MODY and GCK-MODY

Affiliations

Quality of life assessment in patients with HNF1A-MODY and GCK-MODY

Magdalena Szopa et al. Endocrine. 2019 May.

Abstract

Aim: The impact of maturity onset diabetes of the young (MODY) on quality of life (QoL) has never been examined. We assessed disease impact on QoL among patients with HNF1A-MODY and GCK mutation carrier status.

Methods: The study included 80 patients with HNF1A-MODY and 89 GCK gene mutation carriers. We also examined 128 type 1 diabetes (T1DM) patients for comparison. Diabetes-specific QoL was assessed using the Audit of Diabetes Dependent Quality of Life questionnaire.

Results: HNF1A-MODY and GCK-MODY groups had similar mean age (41.7 vs. 38.0 years, respectively) and BMI (24.1 vs. 24.3 kg/m2), whereas T1DM patients were on average younger (34.2 years) with similar BMI (25.0 kg/m2). Less than a third of GCK mutation carriers were on pharmacotherapy (n = 20, 31%), while the majority of HNF1A mutation carriers used oral drugs or insulin (n = 66, 82.5%). While current QoL was similar across the three groups (p = 0.66), two other major indices-the impact of diabetes on QoL and the average weighted impact (AWI)-differed among them (p < 0.001 for both comparisons). The impact of diabetes on patient QoL and AWI observed in both MODY groups was smaller than in T1DM. Etiological diagnosis of diabetes and a diagnosis of retinopathy were the only independent factors influencing the impact of diabetes on QoL and AWI in regression analysis. In HNF1A-MODY, all three major indices of QoL were more heavily influenced for patients on insulin in comparison to other treatment sub-groups.

Conclusion: MODY has a smaller negative impact on QoL compared to T1DM. Mode of treatment further stratifies QoL decline for HNF1A-MODY subjects.

Keywords: Diabetes; MODY; Quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Diabetes mean impact on QoL in patients with HNF1A-MODY, GCK-MODY, and T1DM
Fig. 2
Fig. 2
Diabetes mean impact on specific domains of QoL in patients with HNF1A-MODY GCK-MODY and T1DM
Fig. 3
Fig. 3
Diabetes mean impact on specific domains of QoL in patients with HNF1A-MODY compared to T1DM
Fig. 4
Fig. 4
Diabetes mean impact on specific domains of QoL in patients with HNF1A-MODY according to treatment method

References

    1. L. Fellowfield, What is quality of life. http://www.medicine.ox.ac.uk/bandolier/painres/download/whatis/WhatisQOL... Accessed 10 Nov 2018
    1. L. Fellowfield, WHOQOL. Measuring quality of life, program on mental health. http://www.who.int/mental_health/media/68.pdf. Accessed 10 Nov 2018
    1. El Achhab Y, Nejjari C, Chikri M, Lyoussi B. Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res. Clin. Pract. 2008;80:171–184. doi: 10.1016/j.diabres.2007.12.020. - DOI - PubMed
    1. Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ. Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes. Clin. Outcomes Res. 2016;8:559–571. doi: 10.2147/CEOR.S114699. - DOI - PMC - PubMed
    1. Nielsen HB, Ovesen LL, Mortensen LH, Lau CJ, Joensen LE. Type 1 diabetes, quality of life, occupational status and education level - a comparative population-based study. Diabetes Res. Clin. Pract. 2016;121:62–68. doi: 10.1016/j.diabres.2016.08.021. - DOI - PubMed

Publication types

Substances

Supplementary concepts